Orange Book product · Generic (ANDA)
VALSARTAN
VALSARTAN
At a glance
Apr 21, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 21, 2026
2 mo ago
Today
Pharmaceutical detail
Active ingredient
VALSARTAN
Strength
40MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 218897
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of VALSARTAN
- 2017PREXXARTANBrand (NDA)
NDA 209139 · CARMEL BIOSCIENCES
- 2002DIOVANBrand (NDA)
NDA 021283 · NOVARTIS
- 1996DIOVANBrand (NDA)
NDA 020665 · NOVARTIS
- 2025VALSARTANGeneric (ANDA)
ANDA 216460 · RUBICON RESEARCH
- 2024VALSARTANGeneric (ANDA)
ANDA 218169 · RENATA
- 2024VALSARTANGeneric (ANDA)
ANDA 218991 · ZYDUS LIFESCIENCES
- 2021VALSARTANGeneric (ANDA)
ANDA 214102 · NOVITIUM PHARMA
- 2021VALSARTANGeneric (ANDA)
ANDA 204038 · SCIEGEN PHARMS
- 2021VALSARTANGeneric (ANDA)
ANDA 201618 · DR REDDYS
- 2019VALSARTANGeneric (ANDA)
ANDA 205536 · ALKEM LABS LTD
- 2018VALSARTANGeneric (ANDA)
ANDA 209261 · UNICHEM
- 2018VALSARTANGeneric (ANDA)
ANDA 205347 · SQUARE PHARMS PLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
